Literature DB >> 24567582

Effectiveness of general practice-based health checks: a systematic review and meta-analysis.

Si Si1, John R Moss, Thomas R Sullivan, Skye S Newton, Nigel P Stocks.   

Abstract

BACKGROUND: A recent review concluded that general health checks fail to reduce mortality in adults. AIM: This review focuses on general practice-based health checks and their effects on both surrogate and final outcomes. DESIGN AND
SETTING: Systematic search of PubMed, Embase, and the Cochrane Central Register of Controlled Trials.
METHOD: Relevant data were extracted from randomised trials comparing the health outcomes of general practice-based health checks versus usual care in middle-aged populations.
RESULTS: Six trials were included. The end-point differences between the intervention and control arms in total cholesterol (TC), systolic and diastolic blood pressure (SBP, DBP), and body mass index (BMI) were -0.13 mmol/l (95% confidence interval [CI] = -0.19 to -0.07), -3.65 mmHg (95% CI = -6.50 to -0.81), -1.79 mmHg (95% CI = -2.93 to -0.64), and -0.45 kg/m(2) (95% CI = -0.66 to -0.24), respectively. The odds of a patient remaining at 'high risk' with elevated TC, SBP, DBP, BMI or continuing smoking were 0.63 (95% CI = 0.50 to 0.79), 0.59 (95% CI = 0.28 to 1.23), 0.63 (95% CI = 0.53 to 0.74), 0.89 (95% CI = 0.81 to 0.98), and 0.91 (95% CI = 0.82 to 1.02), respectively. There was little evidence of a difference in total mortality (OR 1.03, 95% CI = 0.90 to 1.18). Higher CVD mortality was observed in the intervention group (OR 1.30, 95% CI = 1.02 to 1.66).
CONCLUSION: General practice-based health checks are associated with statistically significant, albeit clinically small, improvements in surrogate outcome control, especially among high-risk patients. Most studies were not originally designed to assess mortality.

Entities:  

Keywords:  general practice; health check; mortality; primary health care; risk factors; systematic review

Mesh:

Year:  2014        PMID: 24567582      PMCID: PMC3876170          DOI: 10.3399/bjgp14X676456

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  34 in total

1.  Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease.

Authors:  B M Psaty; N S Weiss; C D Furberg; T D Koepsell; D S Siscovick; F R Rosendaal; N L Smith; S R Heckbert; R C Kaplan; D Lin; T R Fleming; E H Wagner
Journal:  JAMA       Date:  1999-08-25       Impact factor: 56.272

2.  Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort.

Authors:  R K Simmons; M Rahman; R W Jakes; M F Yuyun; A R Niggebrugge; S H Hennings; D R R Williams; N J Wareham; S J Griffin
Journal:  Diabetologia       Date:  2010-10-27       Impact factor: 10.122

3.  Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial.

Authors:  D A Wood; K Kotseva; S Connolly; C Jennings; A Mead; J Jones; A Holden; D De Bacquer; T Collier; G De Backer; O Faergeman
Journal:  Lancet       Date:  2008-06-14       Impact factor: 79.321

4.  Effects of an assessment of needs for medical and social services on long-term mortality: a randomized controlled study.

Authors:  H Theobald; L O Bygren; J Carstensen; M Hauffman; P Engfeldt
Journal:  Int J Epidemiol       Date:  1998-04       Impact factor: 7.196

Review 5.  Multiple risk factor interventions for primary prevention of coronary heart disease.

Authors:  S Ebrahim; A Beswick; M Burke; G Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

6.  The Fremantle Primary Prevention Study: a multicentre randomised trial of absolute cardiovascular risk reduction.

Authors:  Tom Brett; Diane Arnold-Reed; Cam Phan; Frances Cadden; William Walker; Wendy Manea-Walley; Noelene Mora; Julie Young; Max Bulsara
Journal:  Br J Gen Pract       Date:  2012-01       Impact factor: 5.386

Review 7.  Systematic review: the value of the periodic health evaluation.

Authors:  L Ebony Boulware; Spyridon Marinopoulos; Karran A Phillips; Constance W Hwang; Kenric Maynor; Dan Merenstein; Renee F Wilson; George J Barnes; Eric B Bass; Neil R Powe; Gail L Daumit
Journal:  Ann Intern Med       Date:  2007-02-20       Impact factor: 25.391

8.  Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial.

Authors:  Simon Stewart; Melinda J Carrington; Carla H Swemmer; Craig Anderson; Nicol P Kurstjens; John Amerena; Alex Brown; Louise M Burrell; Ferdinandus J de Looze; Mark Harris; Joseph Hung; Henry Krum; Mark Nelson; Markus Schlaich; Nigel P Stocks; Garry L Jennings
Journal:  BMJ       Date:  2012-11-20

9.  Effect of screening for Type 2 diabetes on population-level self-rated health outcomes and measures of cardiovascular risk: 13-year follow-up of the Ely cohort.

Authors:  M Rahman; R K Simmons; S H Hennings; N J Wareham; S J Griffin
Journal:  Diabet Med       Date:  2012-07       Impact factor: 4.359

10.  A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile.

Authors:  J S Benner; L Erhardt; M Flammer; R A Moller; N Rajicic; K Changela; C Yunis; S B Cherry; Z Gaciong; E S Johnson; M C J M Sturkenboom; J García-Puig; X Girerd
Journal:  Int J Clin Pract       Date:  2008-08-07       Impact factor: 2.503

View more
  52 in total

1.  [Evidence-based recommendations for the revision of the Austrian periodic health examination].

Authors:  Isolde Sommer; Viktoria Titscher; Birgit Teufer; Irma Klerings; Barbara Nußbaumer-Streit; Monika Szelag; Lisa Affengruber; Gernot Wagner; Anna Glechner; Christina Kien; Agnes Ebenberger; Irmgard Schiller-Frühwirth; Thomas E Dorner; Andrea Siebenhofer; Bernd Haditsch; Herbert Bachler; Uwe Siebert; Gerald Gartlehner
Journal:  Wien Med Wochenschr       Date:  2019-06-11

2.  Screening for increased cardiometabolic risk in primary care: a systematic review.

Authors:  Corine den Engelsen; Paula S Koekkoek; Merijn B Godefrooij; Mark G Spigt; Guy E Rutten
Journal:  Br J Gen Pract       Date:  2014-10       Impact factor: 5.386

3.  Screening Strategies for Unrecognized CKD.

Authors:  Paul Komenda; Claudio Rigatto; Navdeep Tangri
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

4.  Rethinking screening during and after COVID-19: Should things ever be the same again?

Authors:  James A Dickinson; Guylène Thériault; Harminder Singh; Olga Szafran; Roland Grad
Journal:  Can Fam Physician       Date:  2020-08       Impact factor: 3.275

5.  Periodic preventive health visits: a more appropriate approach to delivering preventive services: From the Canadian Task Force on Preventive Health Care.

Authors:  Richard Birtwhistle; Neil R Bell; Brett D Thombs; Roland Grad; James A Dickinson
Journal:  Can Fam Physician       Date:  2017-11       Impact factor: 3.275

6. 

Authors:  Richard Birtwhistle; Neil R Bell; Brett D Thombs; Roland Grad; James A Dickinson
Journal:  Can Fam Physician       Date:  2017-11       Impact factor: 3.275

7. 

Authors:  Christina Korownyk; James McCormack; Michael R Kolber; Scott Garrison; G Michael Allan
Journal:  Can Fam Physician       Date:  2017-09       Impact factor: 3.275

8.  Competing demands and opportunities in primary care.

Authors:  Christina Korownyk; James McCormack; Michael R Kolber; Scott Garrison; G Michael Allan
Journal:  Can Fam Physician       Date:  2017-09       Impact factor: 3.275

9.  2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).

Authors:  Massimo F Piepoli
Journal:  Int J Behav Med       Date:  2017-06

10.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.